Building a Better Stem Cell: Improving the Maturity of Human Stem Cells In Vitro through Bioengineering

Evaluation of Clonal Organoid Heterogeneity at Single Gastroid Resolution

Novel Workflow for High Efficiency Single Cell Isolation of iPSCs with Concurrent Documentation of Clonality

Academia and Industry Go Hand-in-Hand: From ICM and Trophoblasts, Through BBB-on-a-Chip, to ALS and Diabetes Treatments

Applications of Organoid and Organotypic Cultures in Infectious Diseases, Nephrotoxicity, and Highly-relevant Cell-based Assay Development

From Bench to Bedside – Pluripotent Stem Cell Differentiation

Innovative Tools to Reprogram, Engineer, and Culture Pluripotent Stem Cells for GMP Manufacturing

Innovative Tools to Reprogram, Engineer, and Culture Pluripotent Stem Cells for GMP Manufacturing

Differentiating Immune Cells from Human Pluripotent Stem Cells in Feeder- and Serum-Free Cultures

Optimized, Serum-Free, In Vitro Culture Conditions for CRISPR-Mediated Genome Editing of CD34+ Cells

From Pluripotency to Organoids: Liver Incubation Monitoring Identifies Clues for Reproducibility

Towards Therapies Combining Reprogramming and Genetic Engineering

Identification of Drugs Blocking SARS-CoV-2 Infection Using Human Pluripotent Stem Cell-Derived Colonic Organoids

Advanced Brain Organoid Co-Culture Systems

Alexander Disease and Giant Axonal Neuropathy: Cell Biological Insights from Ipsc-Derived Astrocyte and Neuron Disease Models

Gain Deeper Insights into Cellular 3D Structures with Water Immersion Objectives for High-Content Imaging

Next Generation High-Content Electrophysiology Systems for Efficient Functional Characterization of Human iPSC-Derived Neurons